South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram critical care (pty) ltd - infusion (parenteral) - see ingredients - each 25,0 ml suspension contains paclitaxel 150,0 mg

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram critical care (pty) ltd - infusion (parenteral) - see ingredients - each 50,0 ml suspension contains paclitaxel 300,0 mg

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

25ml glass vial -

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

arabian ethicals co. austria - 25ml glass vial - infusion - 6mg/1ml (150mg/25ml) - malignant disease,immunosuppresion-cytotoxics

Ireland - English - HPRA (Health Products Regulatory Authority)

seacross pharmaceuticals limited - docetaxel anhydrous - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - docetaxel - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - docetaxel - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel

Ireland - English - HPRA (Health Products Regulatory Authority)

seacross pharma (europe) limited - docetaxel anhydrous - concentrate for solution for infusion - 20 milligram(s)/millilitre - taxanes; docetaxel

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - docetaxel, quantity: 80 mg - injection, concentrated - excipient ingredients: ethanol absolute; citric acid; polysorbate 80 - breast cancer,metastatic breast cancer,dotax is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed.,dotax in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.,dotax in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress her2 and who previously have not received chemotherapy for metastatic disease,adjuvant treatment of breast cancer,dotax in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with node-positive breast cancer.,doxorubicin and cyclophosphamide followed by dotax in combination with trastuzumab (ac-th) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress her2,dotax in combination with carboplatin and trastuzuma

Australia - English - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - docetaxel, quantity: 20 mg - injection, concentrated - excipient ingredients: polysorbate 80; citric acid; ethanol absolute - breast cancer,metastatic breast cancer,dotax is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed.,dotax in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.,dotax in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours overexpress her2 and who previously have not received chemotherapy for metastatic disease,adjuvant treatment of breast cancer,dotax in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with node-positive breast cancer.,doxorubicin and cyclophosphamide followed by dotax in combination with trastuzumab (ac-th) is indicated for the adjuvant treatment of patients with operable breast cancer whose tumours overexpress her2,dotax in combination with carboplatin and trastuzuma